Return to home page
Searching: all OPAL Libraries
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
 
COMPUTER FILE
Author Somers, Julie.
Title U.S. policy regarding pandemic-influenza vaccines / [Julie Somers, Philip Webre].
Imprint [Washington, D.C.] : U.S. Congressional Budget Office, [2008]

LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  Y 10.2:P 19    ONLINE  
Author Somers, Julie.
Series A CBO paper.
CBO papers.
Subject Influenza -- United States -- States -- Management.
Epidemics -- United States -- States -- Management.
Influenza vaccines -- United States -- States.
Health planning -- United States -- States.
Emergency management -- United States -- States -- Planning.
Influenza, Human -- epidemiology.
Vaccines -- supply & distribution.
United States.
Alt Name Webre, Philip.
United States. Congressional Budget Office.
Add Title United States policy regarding pandemic-influenza vaccines
Description xii, 38 pages : digital, PDF file.
polychrome rdacc
System Details Mode of access: Internet from the CBO web site. Address as of 10/02/2008: http://www.cbo.gov/ftpdocs/95xx/doc9573/09-15-PandemicFlu.pdf ; current access available via PURL.
Note Title from title screen (viewed on Sept. 24, 2008).
"September 2008."
"The report was written by Julie Somers and Philip Webre"--Preface.
Bibliography Note Includes bibliographical references (p. [33]-38).
Contents The market for seasonal-influenza vaccine and the challenge of providing vaccine in a pandemic -- Developing new vaccines -- Investing in new capacity for production -- Stockpiling vaccine -- Options for modifying HHS's plan -- References -- Tables -- Figures -- Boxes.
Summary ..The paper released by CBO today examines that increasingly prominent role -- in developing new vaccines, expanding the capacity of the industry to manufacture them, and procuring stockpiles of prepandemic vaccines.
OCLC # 256484318


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team